Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P11021 (
BiP
)
2,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To investigate the role of each domain in
BiP
/GRP78 function, we have used a full-length recombinant
BiP
engineered to contain two enterokinase sites; one site is located after an N-terminal FLAG epitope, and a second site has been inserted at the junction between the N- and C-terminal domains (FLAG-
BiP
.ent). FLAG-
BiP
.ent oligomerizes into multiple species that interconvert with each other in a slow, concentration- and temperature-dependent equilibrium. Binding of ATP or AMP-PNP (adenosine 5'-(beta, gamma-imino)triphosphate), but not ADP, or of a peptidic substrate induces depolymerization of FLAG-
BiP
.ent and stabilization of monomeric species. Enterokinase cleavage of monomeric, nucleotide-free
BiP
.ent results in the physical dissociation of the 44-kDa N-terminal ATPase fragment (N44.ent) from the 30-kDa C-terminal substrate binding domain (
C30
.ent). Upon dissociation, the freed C-terminal substrate binding domain readily undergoes self-association while N44.ent remains monomeric. Enterokinase cleavage performed in the presence of a synthetic peptide prevents oligomerization of the freed
C30
.ent domain. Addition of ATP during enterokinase cleavage has no effect on
C30
.ent oligomerization. Our data clearly indicate that binding of a specific peptide onto the C-terminal domain, or ATP onto the N-terminal domain, induces internal conformational change(s) within the
C30
domain that result(s) in
BiP
depolymerization.
...
PMID:Substrate binding induces depolymerization of the C-terminal peptide binding domain of murine GRP78/BiP. 975 27
In the present study, we have used a non-denaturing gel electrophoresis assay to characterize the specificity of the peptide-induced depolymerization process of the isolated recombinant C-terminal domain (
C30
) of the molecular chaperone
BiP
, in the presence of specific synthetic peptides and with the neuropeptide Substance P. In the absence of peptidic ligand,
C30
self-associates readily into multiple oligomeric species. Upon peptide addition,
C30
oligomers convert into dimers, then into monomers. Our data indicate that the algorithm we previously developed to predict putative
BiP
binding sites in any protein sequence is also a good indicator as to whether a peptide can efficiently induce depolymerization of the C-terminal peptide binding domain and stimulate the ATPase activity of the full-length protein.
...
PMID:Specificity of peptide-induced depolymerization of the recombinant carboxy-terminal fragment of BiP/GRP78. 1048 74